GT200600207A - Proceso para la síntesis de compuestos orgánicos - Google Patents

Proceso para la síntesis de compuestos orgánicos

Info

Publication number
GT200600207A
GT200600207A GT200600207A GT200600207A GT200600207A GT 200600207 A GT200600207 A GT 200600207A GT 200600207 A GT200600207 A GT 200600207A GT 200600207 A GT200600207 A GT 200600207A GT 200600207 A GT200600207 A GT 200600207A
Authority
GT
Guatemala
Prior art keywords
synthesis
organic compounds
pyrimidinylaminobenzamids
trifluorometil
benzenamine
Prior art date
Application number
GT200600207A
Other languages
English (en)
Spanish (es)
Inventor
Murat Acemoglu
Berthold Schenkel
Wen-Chung Shieh
Song Xue
Erich Widmer
Pedro Garcia Fuentes
Jose Martin Medina
Francisco Vicente Banos
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of GT200600207A publication Critical patent/GT200600207A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GT200600207A 2005-06-09 2006-05-18 Proceso para la síntesis de compuestos orgánicos GT200600207A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68892005P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
GT200600207A true GT200600207A (es) 2007-01-15

Family

ID=37085334

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600207A GT200600207A (es) 2005-06-09 2006-05-18 Proceso para la síntesis de compuestos orgánicos

Country Status (20)

Country Link
US (1) US7709657B2 (enExample)
EP (1) EP1896425B1 (enExample)
JP (1) JP5139273B2 (enExample)
KR (1) KR101319071B1 (enExample)
CN (1) CN101193866B (enExample)
AR (1) AR057351A1 (enExample)
AT (1) ATE483690T1 (enExample)
AU (1) AU2006258116B2 (enExample)
BR (1) BRPI0611924A2 (enExample)
CA (1) CA2610402C (enExample)
DE (1) DE602006017369D1 (enExample)
ES (1) ES2354115T3 (enExample)
GT (1) GT200600207A (enExample)
MX (1) MX2007015420A (enExample)
PE (1) PE20070084A1 (enExample)
PL (1) PL1896425T3 (enExample)
PT (1) PT1896425E (enExample)
RU (1) RU2404167C2 (enExample)
TW (1) TW200710084A (enExample)
WO (1) WO2006135619A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GB0618832D0 (en) * 2006-09-25 2006-11-01 Phoenix Chemicals Ltd Chemical process
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
CN106536303B (zh) 2014-05-16 2019-08-13 罗伯特·博世有限公司 Abs液压单元
KR102335216B1 (ko) 2017-04-26 2021-12-03 삼성전자 주식회사 발광소자 패키지
CN107235910B (zh) * 2017-07-31 2020-04-24 安礼特（上海）医药科技有限公司 一种尼洛胺的合成方法
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI787523B (zh) 2018-06-15 2022-12-21 漢達生技醫藥股份有限公司 達沙替尼十二烷基硫酸鹽之結晶
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
DE69429078T2 (de) * 1993-10-01 2002-07-11 Novartis Ag, Basel Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
US6323366B1 (en) * 1997-07-29 2001-11-27 Massachusetts Institute Of Technology Arylamine synthesis
US6395916B1 (en) * 1998-07-10 2002-05-28 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
US7202367B2 (en) * 2002-05-31 2007-04-10 Rhodia Chimie Process for arylating or vinylating or alkynating a nucleophilic compound
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
PL1896425T3 (pl) 2011-04-29
US20080200691A1 (en) 2008-08-21
CA2610402A1 (en) 2006-12-21
CN101193866B (zh) 2011-01-19
JP5139273B2 (ja) 2013-02-06
EP1896425B1 (en) 2010-10-06
RU2007147927A (ru) 2009-07-20
CN101193866A (zh) 2008-06-04
AU2006258116B2 (en) 2010-11-25
ES2354115T3 (es) 2011-03-10
US7709657B2 (en) 2010-05-04
WO2006135619A1 (en) 2006-12-21
MX2007015420A (es) 2008-02-21
BRPI0611924A2 (pt) 2010-10-05
PE20070084A1 (es) 2007-03-09
AU2006258116A1 (en) 2006-12-21
RU2404167C2 (ru) 2010-11-20
AR057351A1 (es) 2007-11-28
DE602006017369D1 (de) 2010-11-18
EP1896425A1 (en) 2008-03-12
KR101319071B1 (ko) 2013-10-17
PT1896425E (pt) 2010-11-30
CA2610402C (en) 2014-09-16
JP2008545782A (ja) 2008-12-18
KR20080016618A (ko) 2008-02-21
ATE483690T1 (de) 2010-10-15
TW200710084A (en) 2007-03-16

Similar Documents

Publication Publication Date Title
MY146795A (en) Process for the synthesis of organic compounds
WO2007085895A3 (en) Fap inhibitors
MX2012005358A (es) Procedimiento para la preparacion de etexilato de dabigatran.
JO2910B1 (en) Organic compounds
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
GT200900204A (es) Compuestos complejos de hidrato de carbono y hierro
EA201170617A1 (ru) Пиразолиламинопиридины в качестве ингибиторов fak
EA201070467A1 (ru) Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
MX2010004669A (es) Proceso para la preparacion de derivados de isoindol asi como tambien un proceso para la preparacion de sus intermediarios.
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
DK2190426T3 (da) Griseofulvin-analoger til behandling af cancer ved hæmning af centrosomal clusterdannelse
TW200637827A (en) Processes for preparing substituted phenylpyrazole ureas
BR112014032229A2 (pt) método para produção de 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il) piridina-2-carbonitrila, e intermediários da mesma
GB0508318D0 (en) Organic compounds
PL2060568T3 (pl) Odmiany polimorficzne enancjomerycznie czystej erdosteiny
NO20080553L (no) Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander
GT200500311A (es) Compuestos organicos
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
TW200710084A (en) Process for the synthesis of organic compounds
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
IN2012DN02000A (enExample)
WO2007017892A3 (en) Novel compounds as glp-i agonists
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов